Actively Recruiting
Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
Led by University of Milano Bicocca · Updated on 2023-10-11
10000
Participants Needed
1
Research Sites
574 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Autoimmune Hepatitis (AIH) is chronic fibroinflammatory disease of the liver characterized by chronic, relapsing liver inflammation, and a risk for progression to liver failure and need for liver transplantation. No AIH-specific registry does exist in Italy, so that the actual epidemiology of the disease in the country is unknown. This is an observational, retrospective and prospective, multicenter study evaluating incidence, prevalence and disease course of AIH in subjects \> 1 years old in Italy.
CONDITIONS
Official Title
Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All AIH patients living in Italy and aged at least 1 year can be included in the database.
- Willing and able to give informed consent prior to any study specific procedure.
- Diagnosis of AIH according to the most recent published guidelines (EASL).
You will not qualify if you...
- Subject unwilling to participate at the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione IRCCS San Gerardo dei Tintori
Monza, MB, Italy, 20900
Actively Recruiting
Research Team
P
Pietro Invernizzi, MD
CONTACT
A
Alessio Gerussi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here